CASI Pharmaceuticals Inc Logo Image

CASI Pharmaceuticals Inc

CASI Pharmaceuticals Inc has reached its limit for report views.

Please check back to see if CASI Pharmaceuticals Inc has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report and Form 10K

CASI Pharmaceuticals Inc
Order Free Hardcopy

You can request a free hardcopy of this report mailed to you by clicking the button below.

Add Annual Report

Archived Annual Reports

  • CASI Pharmaceuticals Inc
  • CASI Pharmaceuticals Inc
  • CASI Pharmaceuticals Inc

About CASI Pharmaceuticals Inc

Based in Rockville, Maryland

CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States and China. The company’s lead drug candidate includes ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer, which has completed Phase I studies in patients with advanced solid tumors, multiple myeloma, and leukemia, as well as it is completing data for a multi-center Phase II study in patients with platinum resistant ovarian cancer.

Ticker:
CASI
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol